---
stable_id: R-HSA-9018808
display_name: RAC3 binds effectors at the plasma membrane
species: Homo sapiens
summary: 'In its active form, plasma membrane associated RAC3 binds to the following
  effectors:<br>NOX1 complex (Miyano et al. 2009)<br>NOX2 complex (Miyano et al. 2009)<br>NOX3
  complex (Miyano et al. 2009)<br>PAK2 (Bagci et al. 2020; activation of PAK2 downstream
  of RAC3 was demonstrated by Mira et al. 2000, but direct binding was not tested
  in the study)<br>WAVE1 complex, through direct interaction with WASF1 (Bagci et
  al. 2020) and CYFIP1 (Bagci et al. 2020)<br>WAVE2 complex, through direct interaction
  with WASF2 (Bagci et al. 2020) and CYFIP1 (Bagci et al. 2020)<br><br>The following
  proteins are annotated as candidate RAC3 effectors because their interactions with
  RAC3 have not been sufficiently characterized:<br>ABI1 (Bagci et al. 2020)<br>ABI2
  (Bagci et al. 2020)<br>ABL2 (Bagci et al. 2020)<br>AMIGO2 (Bagci et al. 2020)<br>BAIAP2
  (Bagci et al. 2020)<br>BAIAP2L1 (Bagci et al. 2020)<br>BRK1 (Bagci et al. 2020)<br>CAV1
  (Bagci et al. 2020)<br>CDC42 (Bagci et al. 2020)<br>CDC42EP1 (Bagci et al. 2020)<br>DEPDC1B
  (Bagci et al. 2020)<br>DIAPH3 (Bagci et al. 2020)<br>DSG2 (Bagci et al. 2020)<br>EPHA2
  (Bagci et al. 2020)<br>ERBIN (Bagci et al. 2020)<br>FERMT2 (Bagci et al. 2020)<br>GIT1
  (Bagci et al. 2020)<br>GIT2 (Bagci et al. 2020)<br>IL32 (Bagci et al. 2020)<br>ITGB1
  (Bagci et al. 2020)<br>JAG1 (Bagci et al. 2020)<br>KIAA0355 (Bagci et al. 2020)<br>LAMTOR1
  (Bagci et al. 2020)<br>MCAM (Bagci et al. 2020)<br>MPP7 (Bagci et al. 2020)<br>NCKAP1
  (Bagci et al. 2020)<br>NHS (Bagci et al. 2020)<br>PAK1 (Mira et al. 2000: RAC3 induces
  PAK1 activation but direct interaction has not been tested)<br>PAK4 (Bagci et al.
  2020)<br>RAB7A (Bagci et al. 2020)<br>RAPGEF1 (Bagci et al. 2020)<br>SLC1A5 (Bagci
  et al. 2020)<br>SLITRK3 (Bagci et al. 2020)<br>SLITRK5 (Bagci et al. 2020)<br>SNAP23
  (Bagci et al. 2020)<br>STBD1 (Bagci et al. 2020)<br>SWAP70 (Bagci et al. 2020)<br>TAOK3
  (Bagci et al. 2020)<br>TFRC (Bagci et al. 2020)<br>TMPO (Bagci et al. 2020)<br>VAMP3
  (Bagci et al. 2020)<br>VANGL1 (Bagci et al. 2020)<br><br>Active RAC3 does not bind
  to the following established or putative RAC effectors:<br>ANKLE2 (Bagci et al.
  2020)<br>ARAP2 (Bagci et al. 2020)<br>ARFGAP3 (Bagci et al. 2020)<br>ARMCX3 (Bagci
  et al. 2020)<br>CDC42EP4 (Bagci et al. 2020)<br>DOCK1 (Bagci et al. 2020)<br>DOCK5
  (Bagci et al. 2020)<br>ELMO2 (Bagci et al. 2020)<br>HSPE1 (Bagci et al. 2020)<br>LETM1
  (Bagci et al. 2020)<br>NDUFA5 (Bagci et al. 2020)<br>NDUFS3 (Bagci et al. 2020)<br>PLEKHG3
  (Bagci et al. 2020)<br>PLEKHG4 (Bagci et al. 2020)<br>SHTM2 (Bagci et al. 2020)<br>STX5
  (Bagci et al. 2020)<br>VAPB (Bagci et al. 2020)'
---

# RAC3 binds effectors at the plasma membrane
**Reactome ID:** [R-HSA-9018808](https://reactome.org/content/detail/R-HSA-9018808)
**Species:** Homo sapiens

## Summary

In its active form, plasma membrane associated RAC3 binds to the following effectors:<br>NOX1 complex (Miyano et al. 2009)<br>NOX2 complex (Miyano et al. 2009)<br>NOX3 complex (Miyano et al. 2009)<br>PAK2 (Bagci et al. 2020; activation of PAK2 downstream of RAC3 was demonstrated by Mira et al. 2000, but direct binding was not tested in the study)<br>WAVE1 complex, through direct interaction with WASF1 (Bagci et al. 2020) and CYFIP1 (Bagci et al. 2020)<br>WAVE2 complex, through direct interaction with WASF2 (Bagci et al. 2020) and CYFIP1 (Bagci et al. 2020)<br><br>The following proteins are annotated as candidate RAC3 effectors because their interactions with RAC3 have not been sufficiently characterized:<br>ABI1 (Bagci et al. 2020)<br>ABI2 (Bagci et al. 2020)<br>ABL2 (Bagci et al. 2020)<br>AMIGO2 (Bagci et al. 2020)<br>BAIAP2 (Bagci et al. 2020)<br>BAIAP2L1 (Bagci et al. 2020)<br>BRK1 (Bagci et al. 2020)<br>CAV1 (Bagci et al. 2020)<br>CDC42 (Bagci et al. 2020)<br>CDC42EP1 (Bagci et al. 2020)<br>DEPDC1B (Bagci et al. 2020)<br>DIAPH3 (Bagci et al. 2020)<br>DSG2 (Bagci et al. 2020)<br>EPHA2 (Bagci et al. 2020)<br>ERBIN (Bagci et al. 2020)<br>FERMT2 (Bagci et al. 2020)<br>GIT1 (Bagci et al. 2020)<br>GIT2 (Bagci et al. 2020)<br>IL32 (Bagci et al. 2020)<br>ITGB1 (Bagci et al. 2020)<br>JAG1 (Bagci et al. 2020)<br>KIAA0355 (Bagci et al. 2020)<br>LAMTOR1 (Bagci et al. 2020)<br>MCAM (Bagci et al. 2020)<br>MPP7 (Bagci et al. 2020)<br>NCKAP1 (Bagci et al. 2020)<br>NHS (Bagci et al. 2020)<br>PAK1 (Mira et al. 2000: RAC3 induces PAK1 activation but direct interaction has not been tested)<br>PAK4 (Bagci et al. 2020)<br>RAB7A (Bagci et al. 2020)<br>RAPGEF1 (Bagci et al. 2020)<br>SLC1A5 (Bagci et al. 2020)<br>SLITRK3 (Bagci et al. 2020)<br>SLITRK5 (Bagci et al. 2020)<br>SNAP23 (Bagci et al. 2020)<br>STBD1 (Bagci et al. 2020)<br>SWAP70 (Bagci et al. 2020)<br>TAOK3 (Bagci et al. 2020)<br>TFRC (Bagci et al. 2020)<br>TMPO (Bagci et al. 2020)<br>VAMP3 (Bagci et al. 2020)<br>VANGL1 (Bagci et al. 2020)<br><br>Active RAC3 does not bind to the following established or putative RAC effectors:<br>ANKLE2 (Bagci et al. 2020)<br>ARAP2 (Bagci et al. 2020)<br>ARFGAP3 (Bagci et al. 2020)<br>ARMCX3 (Bagci et al. 2020)<br>CDC42EP4 (Bagci et al. 2020)<br>DOCK1 (Bagci et al. 2020)<br>DOCK5 (Bagci et al. 2020)<br>ELMO2 (Bagci et al. 2020)<br>HSPE1 (Bagci et al. 2020)<br>LETM1 (Bagci et al. 2020)<br>NDUFA5 (Bagci et al. 2020)<br>NDUFS3 (Bagci et al. 2020)<br>PLEKHG3 (Bagci et al. 2020)<br>PLEKHG4 (Bagci et al. 2020)<br>SHTM2 (Bagci et al. 2020)<br>STX5 (Bagci et al. 2020)<br>VAPB (Bagci et al. 2020)
